Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Clinical trial NCT06954987 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06954987
- Sponsor
- National Cancer Institute (NCI)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-17
- Primary completion
- 2028-05-15
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.